Hershey, Pa.-based Penn State Health has named two new leaders to its transformation and strategy team, according to a Sept. 24 news release.
Marthe Haverkamp, MD, PhD, has been named vice president of transformation and Matthew Kemmann has been named vice president of strategy. Both leaders started on Sept. 21.
In her new role, Dr. Haverkamp will lead enterprise-wide efforts focused on operational excellence, performance improvement and data-driven decision-making.
Dr. Haverkamp, a physician executive with extensive healthcare transformation experience, most recently served as a senior leader in the Healthcare Industry Group at Alvarez & Marsal, a global professional services firm.
In his new role, Mr. Kemmann will support the system’s enterprise strategic plan. He has nearly two decades of experience in strategic planning, business development, analytics and growth strategy.
Prior to his new role, Mr. Kemmann served as director of strategic planning and analytics at University Hospitals Health System.
“Together, Marthe and Matthew bring highly complementary expertise that will help Penn State Health further align strategy and execution and respond to a rapidly evolving healthcare environment,” Mumtaz Darbar, executive vice president and chief transformation officer for Penn State Health, said in the release. “I am excited about the leadership, expertise and perspective they bring to our organization and look forward to the impact they will make as we continue advancing our mission.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
